Actiphage is a novel bacteriophage-based assay that infects and lyses active Mtb to release bacterial DNA for PCR based detection.
In clinical studies Actiphage has been shown to have:
- higher specificity and sensitivity than current tests for Latent TB Infection (LTBI)
- sensitivity of 73% and specificity of 100% in symptomatic patients with suspected Pulmonary TB (PTB)
- specificity of 94% for all patients, with no change in sensitivity
Simple blood collection and easy sample processing allow for rapid laboratory turnaround time.
Actiphage Research Use Only (RUO) components available shortly – click here to find out more.
General contact form